ON THE MODE OF THE PROLACTIN RELEASE-INHIBITING ACTION OF THE SEROTONIN RECEPTOR BLOCKERS METERGOLINE, METHYSERGIDE, AND CYPROHEPTADINE

被引：76
作者：
KRULICH, L
MCCANN, SM
MAYFIELD, MA
机构：
来源：
ENDOCRINOLOGY | 1981年 / 108卷 / 04期
关键词：
D O I：
10.1210/endo-108-4-1115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1115 / 1124
页数：10
相关论文
共 49 条
[41]   THE GROWTH-HORMONE (GH) AND PROLACTIN (PRL) RELEASE INHIBITING EFFECT OF THE KAPPA-OPIOID RECEPTOR AGONIST BREMAZOCINE (BR) IN RATS [J].
KOENIG, JI ;
CONWAY, S ;
KRULICH, L .
FEDERATION PROCEEDINGS, 1984, 43 (03) :630-630
[42]   LACK OF EFFECT OF M-CHLOROPHENYLPIPERAZINE, A SEROTONIN RECEPTOR AGONIST, IN INFLUENCING PROLACTIN AND TSH RELEASE FROM ANTERIOR-PITUITARY GLAND INVITRO [J].
DIRENZO, G ;
AMOROSO, S ;
TAGLIALATELA, M ;
MAIDA, P ;
BASILE, V .
NEUROENDOCRINOLOGY LETTERS, 1988, 10 (01) :15-18
[43]   MODE OF ACTION OF 1-AMINOADAMANTANES - COMPARATIVE INVESTIGATIONS WITH ISOLATED NERVE-ENDINGS AND BLOOD-PLATELETS ON RELEASE OF SEROTONIN AND DOPAMINE [J].
HAACKE, U ;
STURM, G ;
SUWER, V ;
WESEMANN, W ;
WILDENHAHN, G .
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1977, 27 (07) :1481-1483
[44]   Anticonvulsant and glutamate release-inhibiting properties of the highly potent metabotropic glutamate receptor agonist (2S,2′R,3′R)-2-(2′,3′-dicarboxycyclopropyl) glycine (DCG-IV) [J].
Attwell, PJE ;
Kent, NS ;
Jane, DE ;
Croucher, MJ ;
Bradford, HF .
BRAIN RESEARCH, 1998, 805 (1-2) :138-143
[45]   Unravelling the mode of action of the Tres Cantos Antimalarial Set (TCAMS): investigating the mechanism of potent antimalarial compounds potentially targeting the human serotonin receptor [J].
dos Santos, Benedito Matheus ;
Mallaupoma, Lenna Rosanie Cordero ;
Pecenin, Mateus Fila ;
Mohanty, Abhinab ;
Lu, Angela ;
Bartlett, Paula J. ;
Thomas, Andrew P. ;
Gamo, Francisco-Javier ;
Garcia, Celia R. S. .
MALARIA JOURNAL, 2025, 24 (01)
[46]   Ethanol and estradiol modulate alternative splicing of dopamine D2 receptor messenger RNA and abolish the inhibitory action of bromocriptine on prolactin release from the pituitary gland [J].
Oomizu, S ;
Boyadjeva, N ;
Sarkar, DK .
ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2003, 27 (06) :975-980
[47]   Role of vasoactive intestinal peptide and 5-HT2 receptor subtype in serotonin stimulation of basal and thyrotropin-releasing-hormone-induced prolactin release in vitro from rat pituitary cells [J].
Apfelbaum, ME .
NEUROENDOCRINOLOGY, 1998, 67 (01) :45-50
[48]   ANTISENSE STRATEGY UNRAVELS A DOPAMINE-RECEPTOR DISTINCT FROM THE D2-SUBTYPE, UNCOUPLED WITH ADENYLYL-CYCLASE, INHIBITING PROLACTIN-RELEASE FROM RAT PITUITARY-CELLS [J].
VALERIO, A ;
ALBERICI, A ;
TINTI, C ;
SPANO, P ;
MEMO, M .
JOURNAL OF NEUROCHEMISTRY, 1994, 62 (04) :1260-1266
[49]   Design, synthesis and biological evaluation of new 3-[(4-aryl)piperazin-1-yl]-1-arylpropane derivatives as potential antidepressants with a dual mode of action:: serotonin reuptake inhibition and 5-HT1A receptor antagonism [J].
Oficialdegui, AM ;
Martinez, J ;
Pérez, S ;
Heras, B ;
Irurzun, M ;
Palop, JA ;
Tordera, R ;
Lasheras, B ;
del Río, J ;
Monge, A .
FARMACO, 2000, 55 (05) :345-353
12345